Showing results (31-40 of 111) with videos related to

Sort By:
Pageof 12
Clinical Lymphoma, Myeloma & Leukemia|July 4, 2020
Efficacy of Autologous and Allogeneic Hematopoietic Cell Transplantation in Waldenström Macroglobulinemia: A Systematic Review and Meta-analysisRicardo D Parrondo, Tea Reljic, Madiha Iqbal, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2009
Infliximab for managing steroid-refractory acute graft-versus-host diseaseJoseph Pidala, Jongphil Kim, Teresa Field, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2019
Efficacy of Allogeneic Hematopoietic Cell Transplantation in Cutaneous T Cell Lymphoma: Results of a Systematic Review and Meta-AnalysisMadiha Iqbal, Tea Reljic, Ernesto Ayala, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2015
Myeloablative intravenous pharmacokinetically targeted busulfan plus fludarabine as conditioning for allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphomaErnesto Ayala, Javier Figueroa, Janelle Perkins, et al.
Bone Marrow Transplantation|October 13, 2021
Omission of day +11 methotrexate dose and allogeneic hematopoietic cell transplantation outcomes: results of a systematic review/meta-analysisMohamed A Kharfan-Dabaja, Tea Reljic, Arni Kumar, et al.
Leukemia & Lymphoma|July 3, 2018
Allogeneic hematopoietic cell transplantation is potentially curative in mantle cell lymphoma: results from a single institution studyJose D Sandoval-Sus, Rawan Faramand, Julio Chavez, et al.
Hematology/Oncology and Stem Cell Therapy|May 31, 2020
Allogeneic hematopoietic cell transplantation is an effective treatment for patients with Richter syndrome: A systematic review and meta-analysisSonikpreet Aulakh, Tea Reljic, Farah Yassine, et al.
Alimentary Pharmacology & Therapeutics|July 3, 2026
Risk of Myeloproliferative Neoplasms in Patients With Inflammatory Bowel Disease and Impact on Outcomes: A Multi-Centre Matched AnalysisMohamed H Eldesouki, Ahmed Ibrahim, Muhammed M Marey, et al.
Transplantation and Cellular Therapy|February 9, 2023
A Calcineurin Inhibitor Free Graft Versus Host Disease Prophylaxis for Patients Undergoing Matched Related and Matched Unrelated Donor Allogeneic Hematopoietic Cell TransplantMadiha Iqbal, Felipe A Mendieta Nieto, Kaitlyn M Brannick, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 8, 2020
Outcomes of Hepatosplenic T-Cell Lymphoma: The Mayo Clinic ExperienceLeyla Bojanini, Liuyan Jiang, Alexander J Tun, et al.
Pageof 12